Bluejay Diagnostics Inc (NASDAQ:BJDX) price on Friday, November 15, fall -10.54% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.07.
A look at the stock’s price movement, the close in the last trading session was $0.07, moving within a range at $0.0652 and $0.0741. The beta value (5-Year monthly) was 0.728. Turning to its 52-week performance, $31.28 and $0.07 were the 52-week high and 52-week low respectively. Overall, BJDX moved -33.13% over the past month.
Bluejay Diagnostics Inc’s market cap currently stands at around $1.78 million, with investors looking forward to this quarter’s earnings report slated for on 2024-Mar-28.
Turning to the stock’s technical picture we see that short term indicators suggest on average that BJDX is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend BJDX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
BJDX’s current price about -31.54% and -43.84% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 36.96, while 7-day volatility ratio is 21.96% and 28.53% in the 30-day chart. Further, Bluejay Diagnostics Inc (BJDX) has a beta value of 0.73, and an average true range (ATR) of 0.03.
If we refocus on Bluejay Diagnostics Inc (NASDAQ:BJDX), historical trading data shows that trading volumes averaged 91.27 over the past 10 days and 16.36 million over the past 3 months. The company’s latest data on shares outstanding shows there are 26.88 million shares.
The 0.49% of Bluejay Diagnostics Inc’s shares are in the hands of company insiders while institutional holders own 4.15% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.16 million on 2024-10-15, giving us a short ratio of 0.09. The data shows that as of 2024-10-15 short interest in Bluejay Diagnostics Inc (BJDX) stood at 97.0 of shares outstanding, with shares short rising to 97684.0 registered in 2024-09-13. Current price change has pushed the stock -99.32% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the BJDX stock continues to rise going into the next quarter.
